A prospective randomized controlled trial analyzing the clinical outcomes and patient satisfaction based on the implementation of the clinical pathway for Enhanced Recovery After Surgery program (ERAS CP) following oblique lumbar interbody fusion (OLIF)
- Conditions
- Diseases of the musculoskeletal system and connective tissue
- Registration Number
- KCT0009256
- Lead Sponsor
- Seoul National University Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot yet recruiting
- Sex
- All
- Target Recruitment
- 38
A. Patients who are able to ambulate independently for more than 30 minutes (see below for specific screening details):
i. Patients who, despite intermittent claudication, are able to reach a target distance of more than 30 minutes by taking breaks intermittently during ambulation are included.
ii. Patients who are able to reach a target distance of more than 30 minutes despite experiencing severe pain are also included.
B. Patients who visited the neurosurgery outpatient clinic for surgical treatment due to lumbar degenerative disease, requiring 1-2 segmental fixation between lumbar 2 and sacral 1.
C. Patients who voluntarily agree to participate in the research
A. Patients who have previously undergone lumbar surgery.
B. Patients with muscle weakness of Manual Muscle Testing grade 3 or higher.
C. Patients with coexisting neuropsychiatric disorders, such as depression.
D. Patients with musculoskeletal diseases (inflammatory, myopathic, etc.) and infections other than lumbar degenerative disease.
E. Patients with concurrent malignant disease.
F. Patients who do not wish to participate in the research
Study & Design
- Study Type
- Interventional Study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method umeric Rating Scale for back pain and leg pain
- Secondary Outcome Measures
Name Time Method umeric Rating Scale for back pain and leg pain;First ambulation time;First self-urination time;Total analgesic consumption;Patient satisfaction scale;Complication;30-day readmission;Medial cost (inhospital);Length of stay